# High-dose Dual Therapy with Different Administration Frequencies

> **NCT05901051** · PHASE4 · COMPLETED · sponsor: **Shanghai Jiao Tong University School of Medicine** · enrollment: 327 (actual)

## Conditions studied

- Helicobacter Pylori Infection

## Interventions

- **DRUG:** vonoprazan
- **DRUG:** Amoxicillin

## Key facts

- **NCT ID:** NCT05901051
- **Lead sponsor:** Shanghai Jiao Tong University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-30
- **Primary completion:** 2023-09-10
- **Final completion:** 2023-09-30
- **Target enrollment:** 327 (ACTUAL)
- **Last updated:** 2024-12-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05901051

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05901051, "High-dose Dual Therapy with Different Administration Frequencies". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT05901051. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*